Misfeldt Dayton

Average Profitability
11.56%
Insider Buys Quantity
4
Insider Buys Sum
$8.9M
Insider Sells Quantity
6
Insider Sells Sum
$9.54M

Insider Activity of Misfeldt Dayton

The largest purchase of all time was on 2010-06-30 and amounted to 23824450 shares of Viracta Therapeutics, Inc. for $6.55M.

The largest sale of all time was on 2014-08-08 and amounted to 675000 shares of Viracta Therapeutics, Inc. for $4.47M.

Biography of Misfeldt Dayton

No biography is available at this moment.

2017-10-27PurchaseViracta Therapeutics, Inc.
VIRX
director
400,000
1.5465%
$2.00$800,000+25.12%
2015-12-21PurchaseViracta Therapeutics, Inc.
VIRX
director
1.75M
2.2894%
$0.84$1.47M-26.14%
2015-07-24SaleViracta Therapeutics, Inc.
VIRX
director
635,702
3.0682%
$3.46$2.2M-15.63%
2014-08-28SaleViracta Therapeutics, Inc.
VIRX
200,000
0.3348%
$7.89$1.58M-69.28%
2014-08-27SaleViracta Therapeutics, Inc.
VIRX
100,700
0.165%
$8.16$822,014-70.96%
2014-08-12SaleViracta Therapeutics, Inc.
VIRX
37,100
0.0616%
$6.77$251,230-63.95%
2014-08-11SaleViracta Therapeutics, Inc.
VIRX
31,600
0.0523%
$6.90$218,103-64.73%
2014-08-08SaleViracta Therapeutics, Inc.
VIRX
675,000
1.1015%
$6.62$4.47M-63.58%
2010-06-30PurchaseViracta Therapeutics, Inc.
VIRX
23.82M
6.2843%
$0.28$6.55M-14.89%
2009-10-30PurchaseViracta Therapeutics, Inc.
VIRX
333,166
$0.22$73,297+62.16%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.